FitBionic completes $2.2M funding round with KMG Capital Partners, CID4 and High Country Venture

NewsGuard 100/100 Score

FitBionic has completed a $2.2 million funding round with a team led by KMG Capital Partners, with High Country Venture and the Colorado Institute for Drug, Device and Diagnostic Development (CID4). The investment was developed in support of the global launch of FitBionic's currently available first product, the FitBionic Foot, and as a bridge to the company's Series A financing, which is expected in 2014.

“FitBionic's management team are leaders in the prosthetics industry. I believe their patient-outcomes centered technologies and services will make a significant difference in the lives of amputees.”

Eythor Bender, FitBionic CEO, commented, "FitBionic is the first prosthetics company to focus on amputee wellness and on providing medical devices for the growing diabetic population. Since joining this team four months ago, I've been moved by the funding communities' excitement about an emerging company offering affordable bionics. We look forward to benefiting from KMG's expertise in health care development and High Country Venture's focus on life science technologies. CID4 in particular supports our goal of making Colorado a hub of U.S. bionics development."

Mats Wahlstrom, CEO of KMG, added, "FitBionic's management team are leaders in the prosthetics industry. I believe their patient-outcomes centered technologies and services will make a significant difference in the lives of amputees."

"High Country Venture believes that FitBionic will be more than just a good investment—it's prepared to offer a new, holistic paradigm of prosthetic care for diabetics and other amputees," said Mark Lupa, High Country Venture partner.

Through this investment, partners Kerry Hicks and Javier Vergne-Morell of KMG, Mark Lupa, and Kevin M. Smith, President and CEO of CID4, will join FitBionic's board of directors. FitBionic's founder and executive management will retain significant equity interests in the company, as well as board representation by Eythor Bender and Jerome Rifkin, FitBionic founder and Chief Technology Officer.

Source:

FitBionic

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases